Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response.
about
Fatal attraction: how bacterial adhesins affect host signaling and what we can learn from themGenetic Diversity and Virulence Determinants of Escherichia coli Strains Isolated from Patients with Crohn's Disease in Spain and Chile.Identification of Pathogenic Factors in Klebsiella pneumoniae Using Impedimetric Sensor Equipped with Biomimetic Surfaces.Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicityInfectious etiopathogenesis of Crohn's diseaseThe microbial basis of inflammatory bowel diseases.Recent advances in adherence and invasion of pathogenic Escherichia coliUnderstanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Pathogenesis of Crohn's disease: Bug or no bug.Ribonucleotide reductase NrdR as a novel regulator for motility and chemotaxis during adherent-invasive Escherichia coli infection.Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli.A High-resolution Typing Assay for Uropathogenic Escherichia coli Based on Fimbrial Diversity.Differentiation of Crohn's Disease-Associated Isolates from Other Pathogenic Escherichia coli by Fimbrial Adhesion under Shear Force.Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformationPathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell linesSingle clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis in Escherichia coli O2:H6.Pathogenesis of adherent-invasive Escherichia coli.Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.The Adherent/Invasive Escherichia coli Strain LF82 Invades and Persists in Human Prostate Cell Line RWPE-1, Activating a Strong Inflammatory Response.The gut microbiota and inflammatory bowel diseases.A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli.Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.Using murine colitis models to analyze probiotics-host interactions.Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin.GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease.Genome-based Definition of an Inflammatory Bowel Disease-associated Adherent-Invasive Escherichia coli Pathovar.Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease.Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.The role of major virulence factors of AIEC involved in inflammatory bowl disease-a mini-review.RINspector: a Cytoscape app for centrality analyses and DynaMine flexibility prediction.Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.Comparative genomics reveals new single-nucleotide polymorphisms that can assist in identification of adherent-invasive Escherichia coli.Precision antimicrobial therapeutics: the path of least resistance?
P2860
Q26828552-2290C8B0-9663-48F8-8BC8-B96C89D437ADQ30352386-DBBE6690-E00B-44EC-B355-A7974BADA7F2Q33858475-31CB3A77-2BC2-4FA2-A61A-BEDAEB742D57Q33906911-52EFD7D4-42A7-4857-BFD5-57ED443A8E32Q34048001-4988851D-0778-438A-9099-09E7FD82EE5CQ34168490-BB79E5B0-8C47-4431-BDDE-10A6E0FE049AQ34311522-7F24292A-6B04-43F4-A2A2-A5B1DF713903Q34429054-98C43873-56D4-446B-A204-AD2CB11E4D3BQ34786166-FAB165FE-8413-4136-B4D0-21C9C8CD16BCQ35075535-62F8D7F3-9A6C-4A84-8CA9-4135503EF19BQ35187606-D4E33CE0-7E6E-41D8-9C63-3804E3D26118Q35271319-298F251E-CD8D-4B42-9007-25ECFD32D1BAQ35820873-36463A02-96FD-44D1-907A-D9FA039B908EQ36849740-1B9ED587-073F-4372-A9A8-0D5FC0C5A483Q37057409-9BA96FC4-20E0-40E9-8DAA-DE909BDB5B8BQ37204032-DFD01372-0D77-4475-B512-2E3A7B712A74Q37264192-40D5DC63-0CE3-4AEF-9301-D111CE41F66FQ37613036-1E3518C0-EE64-43DB-ABCE-A48A79967FCBQ37644384-A39104C1-FD0B-40BE-9BE4-C86D29B2E9BBQ38141160-7AEBEE70-F169-4C9D-A47E-34173FF4BB6EQ38149113-843399FB-D550-4A20-A025-88F389DA6037Q38648792-A000F252-1C68-458F-8822-9E1952E20E79Q38747897-83EB0153-3A30-459A-92A8-4DF176675F73Q38884056-2DCC1AB6-2D0F-48A1-87A3-358DC3A970A7Q40044097-E5BC7391-E595-4E3C-99BB-DCF71A372BEDQ40073307-4C9087EE-65A1-4EBC-9E58-5B04854E6125Q40084224-02CB190B-AC3B-420D-AB08-F1A70CF88296Q40149385-6E64103F-FB01-47ED-9E80-8FECA13386B5Q40381056-CEB1A914-C486-4116-B1AD-2226C23E24DEQ40906017-E44B170C-FF93-4BFE-9186-000F8D3BE617Q40963090-E15CC9DB-7859-4290-B937-DE787C4C5C57Q41213103-60499AB3-18D2-4980-B90D-74CC82FBCDE8Q41387395-5089AE44-F838-4CCE-B2D7-7A8141332717Q41543377-E36D6219-77DF-44F8-9EB2-58E472BBEC40Q41997378-524433E4-256F-4FDD-81DE-E8E6A02E6EEAQ47314507-9DACC572-8BA4-4165-923A-D70F04D356B1Q47653629-5E2420E5-E66A-4FDF-965F-6727B51A4BEAQ48267704-B0262276-4224-42A8-A14C-E0FCF93CC54EQ49207699-EE1FC372-C7C9-4C97-9102-7297929FB43DQ53704392-FB60AB5E-7AF8-4B8E-B2B2-F84904EFEEDB
P2860
Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Point mutations in FimH adhesi ...... estinal inflammatory response.
@ast
Point mutations in FimH adhesi ...... estinal inflammatory response.
@en
Point mutations in FimH adhesi ...... estinal inflammatory response.
@nl
type
label
Point mutations in FimH adhesi ...... estinal inflammatory response.
@ast
Point mutations in FimH adhesi ...... estinal inflammatory response.
@en
Point mutations in FimH adhesi ...... estinal inflammatory response.
@nl
prefLabel
Point mutations in FimH adhesi ...... estinal inflammatory response.
@ast
Point mutations in FimH adhesi ...... estinal inflammatory response.
@en
Point mutations in FimH adhesi ...... estinal inflammatory response.
@nl
P2093
P2860
P50
P921
P1433
P1476
Point mutations in FimH adhesi ...... estinal inflammatory response.
@en
P2093
Corinne Gower-Rousseau
Dagmara Kisiela
Evgeni Sokurenko
Maria Billig
Nicolas Dreux
Richard Bonnet
Sujay Chattopadhyay
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003141
P50
P577
2013-01-24T00:00:00Z